Literature DB >> 15688011

Low daunomycin concentrations protect colorectal cancer cells from hypoxia-induced apoptosis.

Chantal Lechanteur1, Nathalie Jacobs, Roland Greimers, Valérie Benoît, Valérie Deregowski, Alain Chariot, Marie-Paule Merville, Vincent Bours.   

Abstract

Hypoxia, a common feature of solid tumors, is a direct stress that triggers apoptosis in many cell types. Poor or irregular tumor vascularization also leads to a decreased drug diffusion and cancer cells distant from blood vessels (hypoxic cells) are exposed to low drug concentrations. In this report, we show that low daunomycin concentrations protect HCT116 colorectal cancer cells from hypoxia-induced apoptosis. While hypoxia induced p53 accumulation without expression of its responsive genes (bax and p21), daunomycin treatment restored p53 transactivation activity and cell cycle progression. We also demonstrated a role for Akt activation in daunomycin-induced protection through phosphorylation and inactivation of the Bcl-2 family proapoptotic factor Bad. Our data therefore suggest that chemotherapy could possibly, because of low concentrations in poorly vascularized tumors, protect cancer cells from hypoxia-induced cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688011     DOI: 10.1038/sj.onc.1208436

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  2 in total

1.  The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.

Authors:  Marina Zemskova; Eva Sahakian; Svetlana Bashkirova; Michael Lilly
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

2.  An In Vitro Study of the Neurotoxic Effects of N-Benzylpiperazine: A Designer Drug of Abuse.

Authors:  Karolina Persona; Anna Polus; Joanna Góralska; Anna Gruca; Aldona Dembińska-Kieć; Wojciech Piekoszewski
Journal:  Neurotox Res       Date:  2016-02-09       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.